Published in Oncogene on August 23, 2010
An interleukin-17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapy. Nat Med (2013) 3.00
Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy. J Exp Med (2011) 2.04
Involvement of interleukin-21 in the regulation of colitis-associated colon cancer. J Exp Med (2011) 1.27
A novel pro-lymphangiogenic function for Th17/IL-17. Blood (2011) 1.08
IL-17A is produced by breast cancer TILs and promotes chemoresistance and proliferation through ERK1/2. Sci Rep (2013) 1.03
IL-17 mediated inflammation promotes tumor growth and progression in the skin. PLoS One (2012) 1.01
Th17 and non-Th17 interleukin-17-expressing cells in chronic lymphocytic leukemia: delineation, distribution, and clinical relevance. Haematologica (2011) 0.99
The gastrointestinal tumor microenvironment. Gastroenterology (2013) 0.99
The role of interleukin 17 in tumour proliferation, angiogenesis, and metastasis. Mediators Inflamm (2014) 0.98
Association between IL17 polymorphisms and risk of cervical cancer in Chinese women. Clin Dev Immunol (2012) 0.98
Identification of outcome-correlated cytokine clusters in chronic lymphocytic leukemia. Blood (2011) 0.97
NFAT1 supports tumor-induced anergy of CD4(+) T cells. Cancer Res (2012) 0.91
Promotion of lung tumor growth by interleukin-17. Am J Physiol Lung Cell Mol Physiol (2014) 0.87
Increased circulating Th17 cells after transarterial chemoembolization correlate with improved survival in stage III hepatocellular carcinoma: a prospective study. PLoS One (2013) 0.86
Th17 cells are involved in the local control of tumor progression in primary intraocular lymphoma. PLoS One (2011) 0.85
Imiquimod attenuates the growth of UVB-induced SCC in mice through Th1/Th17 cells. Mol Carcinog (2012) 0.84
Correlations between immune response and vascularization qRT-PCR gene expression clusters in squamous cervical cancer. Mol Cancer (2015) 0.83
Immunomodulatory action of dietary fish oil and targeted deletion of intestinal epithelial cell PPARδ in inflammation-induced colon carcinogenesis. Am J Physiol Gastrointest Liver Physiol (2011) 0.83
Type17 T-cells in central nervous system autoimmunity and tumors. J Clin Immunol (2012) 0.83
Plasticity of γδ T Cells: Impact on the Anti-Tumor Response. Front Immunol (2014) 0.83
Personalising pancreas cancer treatment: When tissue is the issue. World J Gastroenterol (2014) 0.82
Tumor-released survivin induces a type-2 t cell response and decreases cytotoxic T cell function, in vitro. Cancer Microenviron (2012) 0.82
Decreased Anti-Tumor Cytotoxic Immunity among Microsatellite-Stable Colon Cancers from African Americans. PLoS One (2016) 0.81
IL-17-dependent, IFN-gamma-independent tumor rejection is mediated by cytotoxic T lymphocytes and occurs at extraocular sites, but is excluded from the eye. J Immunol (2011) 0.81
Generation and immunologic functions of Th17 cells in malignant gliomas. Cancer Immunol Immunother (2012) 0.81
Targeting the Tumor Microenvironment: The Protumor Effects of IL-17 Related to Cancer Type. Int J Mol Sci (2016) 0.80
LAP TGF-Beta Subset of CD4(+)CD25(+)CD127(-) Treg Cells is Increased and Overexpresses LAP TGF-Beta in Lung Adenocarcinoma Patients. Biomed Res Int (2015) 0.79
Interleukin-17 (IL-17) and IL-1 activate translation of overlapping sets of mRNAs, including that of the negative regulator of inflammation, MCPIP1. J Biol Chem (2013) 0.79
IL-17E synergizes with EGF and confers in vitro resistance to EGFR-targeted therapies in TNBC cells. Oncotarget (2016) 0.79
An essential role for decorin in bladder cancer invasiveness. EMBO Mol Med (2013) 0.78
Inflammation, cytokines, the IL-17/IL-6/STAT3/NF-κB axis, and tumorigenesis. Drug Des Devel Ther (2015) 0.77
Role of IL-17 in Glioma Progression. J Spine Neurosurg (2013) 0.77
The glutaredoxin/S-glutathionylation axis regulates interleukin-17A-induced proinflammatory responses in lung epithelial cells in association with S-glutathionylation of nuclear factor κB family proteins. Free Radic Biol Med (2014) 0.77
Identification and characterization of distinct IL-17F expression patterns and signaling pathways in chronic lymphocytic leukemia and normal B lymphocytes. Immunol Res (2015) 0.76
Scutellaria barbata D. Don extract inhibits the tumor growth through down-regulating of Treg cells and manipulating Th1/Th17 immune response in hepatoma H22-bearing mice. BMC Complement Altern Med (2017) 0.75
Immune-checkpoint protein VISTA critically regulates the IL-23/IL-17 inflammatory axis. Sci Rep (2017) 0.75
The hallmarks of cancer. Cell (2000) 113.05
Inflammation and cancer. Nature (2002) 53.78
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature (2006) 46.36
Cancer-related inflammation. Nature (2008) 34.21
The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell (2006) 33.94
TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity (2006) 29.29
Transforming growth factor-beta induces development of the T(H)17 lineage. Nature (2006) 25.91
IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol (2007) 16.21
Interleukin-17 family members and inflammation. Immunity (2004) 16.16
STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer (2009) 15.45
TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature (2008) 14.26
Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol (2007) 13.70
Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol (2007) 12.76
Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med (2001) 12.38
Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity (2008) 10.26
The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat Immunol (2008) 9.64
Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol (2006) 9.42
The immunobiology of cancer immunosurveillance and immunoediting. Immunity (2004) 9.39
T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med (1996) 8.59
CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell (2009) 8.54
Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. Cancer Cell (2009) 8.21
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis (2009) 7.55
A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med (2009) 7.45
Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood (2008) 6.81
Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J Immunol (2007) 6.32
Altered macrophage differentiation and immune dysfunction in tumor development. J Clin Invest (2007) 6.31
IL-23 promotes tumour incidence and growth. Nature (2006) 6.30
Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol (1999) 6.15
CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science (2009) 6.14
A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat Immunol (2008) 6.09
Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity (1995) 5.96
IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J Immunol (1998) 5.79
Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev (2003) 5.57
Regulation of inflammatory responses by IL-17F. J Exp Med (2008) 5.56
IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J Immunol (2006) 5.27
The role of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer (2005) 5.07
IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. J Exp Med (2009) 5.05
Human T cell responses against melanoma. Annu Rev Immunol (2006) 4.99
Interleukin-17 promotes angiogenesis and tumor growth. Blood (2002) 4.90
Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood (2009) 4.80
Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J Clin Invest (2009) 4.74
T helper 17 cells promote cytotoxic T cell activation in tumor immunity. Immunity (2009) 4.69
Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment. Cancer Cell (2009) 4.56
Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am J Respir Cell Mol Biol (2001) 4.56
Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc Natl Acad Sci U S A (2006) 4.51
IL-17: prototype member of an emerging cytokine family. J Leukoc Biol (2002) 4.39
Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell (2004) 4.23
IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J Immunol (2003) 4.13
Endogenous IL-17 contributes to reduced tumor growth and metastasis. Blood (2009) 4.13
Identification of IL-17-producing FOXP3+ regulatory T cells in humans. Proc Natl Acad Sci U S A (2009) 4.10
IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol (2001) 3.91
Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J Immunol (2007) 3.81
Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat Med (2001) 3.81
Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood (2004) 3.59
Regulatory T cells in cancer. Blood (2006) 3.56
Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells. Eur J Immunol (2009) 3.42
T(H)17 cells in tumour immunity and immunotherapy. Nat Rev Immunol (2010) 3.39
Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis. J Immunol (2008) 3.22
Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism. Blood (2002) 3.17
Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor. J Biol Chem (2006) 3.16
Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction. J Exp Med (2000) 3.14
TNF-alpha in promotion and progression of cancer. Cancer Metastasis Rev (2006) 3.14
Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing. Clin Cancer Res (2008) 3.09
Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients. J Hepatol (2009) 2.84
Evidence for a cross-talk between human neutrophils and Th17 cells. Blood (2009) 2.75
Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways. J Immunol (2003) 2.50
Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth. Nat Med (2010) 2.44
Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-kappaB. J Biol Chem (1998) 2.43
The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans. J Clin Invest (2009) 2.42
CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. Cancer Res (2005) 2.38
Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer. Proc Natl Acad Sci U S A (2008) 2.33
Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production. J Immunol (2001) 2.28
Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development. J Exp Med (2007) 2.25
Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice. Cancer Res (1999) 2.23
Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-alpha, and granulocyte-colony-stimulating factor by human airway epithelial cells. Am J Respir Cell Mol Biol (2002) 2.18
The prevalence of Th17 cells in patients with gastric cancer. Biochem Biophys Res Commun (2008) 2.12
IL-17 promotes tumor development through the induction of tumor promoting microenvironments at tumor sites and myeloid-derived suppressor cells. J Immunol (2010) 2.12
Role of macrophages in tumour progression. Immunol Lett (2009) 2.07
Type 17 CD8+ T cells display enhanced antitumor immunity. Blood (2009) 2.02
Tumor microenvironments direct the recruitment and expansion of human Th17 cells. J Immunol (2009) 1.91
Cytokine profiling of macrophages exposed to Porphyromonas gingivalis, its lipopolysaccharide, or its FimA protein. Infect Immun (2005) 1.77
Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate. Prostate (2003) 1.59
Cutting edge: in vitro generated Th17 cells maintain their cytokine expression program in normal but not lymphopenic hosts. J Immunol (2009) 1.54
Induction of a distinct CD8 Tnc17 subset by transforming growth factor-beta and interleukin-6. J Leukoc Biol (2007) 1.52
Neutrophil recruitment by interleukin-17 into rat airways in vivo. Role of tachykinins. Am J Respir Crit Care Med (1999) 1.49
Soluble and transmembrane isoforms of novel interleukin-17 receptor-like protein by RNA splicing and expression in prostate cancer. J Biol Chem (2001) 1.44
Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis. J Immunol (2002) 1.39
IL-17-induced cytokine release in human bronchial epithelial cells in vitro: role of mitogen-activated protein (MAP) kinases. Br J Pharmacol (2001) 1.38
The IL-17/IL-23 axis of inflammation in cancer: friend or foe? Curr Opin Investig Drugs (2009) 1.36
Interleukin-17: an emerging role in lung inflammation. Am J Respir Cell Mol Biol (2003) 1.36
Increased elastase and myeloperoxidase activity associated with neutrophil recruitment by IL-17 in airways in vivo. J Allergy Clin Immunol (2000) 1.32
Increased matrix metalloproteinase-9 concentration and activity after stimulation with interleukin-17 in mouse airways. Thorax (2004) 1.29
Malignant B cells skew the balance of regulatory T cells and TH17 cells in B-cell non-Hodgkin's lymphoma. Cancer Res (2009) 1.27
Characterizing tumor-promoting T cells in chemically induced cutaneous carcinogenesis. Proc Natl Acad Sci U S A (2007) 1.26
Pretreatment frequency of circulating IL-17+ CD4+ T-cells, but not Tregs, correlates with clinical response to whole-cell vaccination in prostate cancer patients. Int J Cancer (2009) 1.24
The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer. Int J Cancer (2009) 1.22
Modulation of bronchial epithelial cells by IL-17. J Allergy Clin Immunol (2001) 1.22
A role of GM-CSF in the accumulation of neutrophils in the airways caused by IL-17 and TNF-alpha. Eur Respir J (2003) 1.20
Enhanced expression and clinical significance of CC-chemokine MIP-3 alpha in hepatocellular carcinoma. Scand J Immunol (2006) 1.17
Putative association of a TLR9 promoter polymorphism with atopic eczema. Allergy (2007) 1.39
Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA). J Exp Med (1994) 0.98
Human ovarian surface epithelial cells immortalized with hTERT maintain functional pRb and p53 expression. Cell Prolif (2007) 0.96
Localization of the gene for the Wiskott-Aldrich syndrome between two flanking markers, TIMP and DXS255, on Xp11.22-Xp11.3. Genomics (1991) 0.94
Proton MR spectroscopy of squamous cell carcinoma of the upper aerodigestive tract: in vitro characteristics. AJNR Am J Neuroradiol (1996) 0.93
Successful treatment of acrodermatitis continua suppurativa with topical tacrolimus 0.1% ointment. Br J Dermatol (2004) 0.92
Characterization of different courses of atopic dermatitis in adolescent and adult patients. Allergy (2013) 0.90
Effects of epidermal growth factor and Clostridium difficile toxin B in a model of mucosal injury. J Pediatr Surg (1997) 0.89
Procalcitonin: a useful discriminator between febrile conditions of different origin in hemato-oncological patients? Ann Hematol (2003) 0.88
The role of prophylactic cholecystectomy during splenectomy in children with hereditary spherocytosis. J Pediatr Surg (1999) 0.83
Nonanatomic hepatic resection with a pledgetted suturing technique. J Pediatr Surg (2001) 0.83
[Somatization and alexithymia in male infertility. A replication study]. Hautarzt (2003) 0.82
[Associated diseases and differential diagnostic considerations in childhood atopic eczema]. Hautarzt (2007) 0.81
The modified Puestow procedure for complicated hereditary pancreatitis in children. J Pediatr Surg (2000) 0.81
A new RFLP marker, SP282, at the btk locus for genetic analysis in X-linked agammaglobulinaemia families. Prenat Diagn (1994) 0.77
Cystic fibrosis-drug therapy. J Pediatr Health Care (1996) 0.77
Use of pledget in the repair of diaphragmatic anomalies. J Pediatr Surg (1991) 0.76
A modification of operative laparoscopic technique to permit removal of an ectopic pregnancy without morcellation. Am J Obstet Gynecol (1990) 0.75
[On the affiliation of student nurses in a district station in Berlin]. Agnes Karll Schwest Krankenpfleger (1968) 0.75
[Christmas with handicapped children in the year 1946]. Krankenpflege (Frankf) (1981) 0.75
Splenic flexure volvulus: a complication of pseudoobstruction in infancy. AJR Am J Roentgenol (1985) 0.75
[Home nursing]. Krankenpflege (Frankf) (1973) 0.75
Propofol use during neuropsychiatric examination under sedation. Anesthesiology (1995) 0.75
A specific histochemical method for phospholipids and sulpholipids. Histochem J (1970) 0.75
Absorption in the isolated bowel segment. J Pediatr Gastroenterol Nutr (1993) 0.75
[Observations of the mental sequela of injury]. Agnes Karll Schwest Krankenpfleger (1971) 0.75
[The aging person from the viewpoint of the public health nurse]. Krankenpflege (Frankf) (1972) 0.75
Catheter care in pediatric hyperalimentation. RN (1975) 0.75
Nutrient intake in elderly women after femoral neck fracture. Proc Nutr Soc (1979) 0.75
Acute iron intoxication with intestinal infarction managed in part by small bowel resection. Clin Toxicol (1975) 0.75